Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

Overview of attention for article published in New England Journal of Medicine, March 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 81 news outlets
blogs: 2 blogs
policy: 1 policy source
twitter: 331 X users
patent: 1 patent
facebook: 1 Facebook page

wikipedia: 4 Wikipedia pages
reddit: 2 Redditors
video: 1 YouTube creator
guideline: 10 clinical guideline sources
podcasts: 3 podcasts

Readers on

mendeley: 400 Mendeley

So far, Altmetric has seen 8 episodes from 3 podcasts.

S1 Episode 6: Radiation Oncology and Its Role in the Treatment of Endometrial Cancer

Medscape InDiscussion: Endometrial Cancer, 24 Oct 2024

Drs Ursula A. Matulonis and Akila N. Viswanathan discuss the role of radiation therapy in endometrial cancer, including staging…

Radiation Oncology and Its Role in the Treatment of Endometrial Cancer

Medscape InDiscussion: Endometrial Cancer, 24 Oct 2024

Drs Ursula A. Matulonis and Akila N. Viswanathan discuss the role of radiation therapy in endometrial cancer, including staging…

S1 Episode 5: Immunotherapy, Novel Therapies, and Shared Decision-Making in Advanced Endometrial Cancer

Medscape InDiscussion: Endometrial Cancer, 25 Sep 2024

Drs Ursula A. Matulonis and Mansoor Mirza discuss immunotherapy trials, novel therapies such as CDK4/6 inhibitors and antibody-dr…

Immunotherapy, Novel Therapies, and Shared Decision-Making in Advanced Endometrial Cancer

Medscape InDiscussion: Endometrial Cancer, 25 Sep 2024

Drs Ursula A. Matulonis and Mansoor Mirza discuss immunotherapy trials, novel therapies such as CDK4/6 inhibitors and antibody-dr…

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 4 additional posts.